back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-02-05 13:39 Tx date 2020-01-28 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,181,936
+48,800 vol $24.22 each |
566,300 | |
| Filed 2019-02-01 Tx date 2019-01-29 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$703,499
+87,500 vol $8.04 each |
517,500 | |
| Filed 2018-02-06 Tx date 2018-02-01 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$977,999
+150,000 vol $6.52 each |
430,000 | |
| Filed 2017-12-04 Tx date 2017-11-20 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,456
+3,800 vol $5.12 each |
3,800 | |
| Filed 2017-12-04 Tx date 2017-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-07-14 Tx date 2017-07-05 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,268,000
+280,000 vol $8.10 each |
280,000 | |
| Filed 2017-07-14 Tx date 2017-07-03 |
$AUPH
Aurinia Pharmaceuticals Inc. |
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|